James B. Lorens
Impact in
- Immunology top 1%
- Phagocytosis and Immune Regulation
- Immune Cell Function and Interaction
- Oncology top 2%
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Angiogenesis and VEGF in Cancer 14
- CRISPR and Genetic Engineering 10
- RNA Interference and Gene Delivery 9
- Oncology 61
- Pancreatic and Hepatic Oncology Research 30
- Cancer Cells and Metastasis 15
- Cancer Immunotherapy and Biomarkers 14
- Co-authors
- David Micklem (38 shared papers)Garry P. Nolan (8 shared papers)Wolfgang Link (5 shared papers)Crina Tiron (10 shared papers)Fabian Zanella (1 shared paper)Hallvard Haugen (8 shared papers)Christine Gjerdrum (4 shared papers)Susan Swift (4 shared papers)
- Journals
- Cancer Research (11 papers)Journal of Clinical Oncology (10 papers)PLoS ONE (5 papers)Frontiers in Immunology (4 papers)Journal of Thoracic Oncology (3 papers)
- Partner nations
- NorwayUnited StatesFrance
In The Last Decade
James B. Lorens
140 papers receiving 5.6k citations
James B. Lorens's Hit Papers
Peers
Comparison fields: 5 of 137
- Immunology 1.6k
- Oncology 1.6k
- Molecular Biology 3.1k
- Cancer Research 655
- Biophysics 188
Countries citing papers authored by James B. Lorens
This map shows the geographic impact of James B. Lorens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James B. Lorens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James B. Lorens more than expected).
Fields of papers citing papers by James B. Lorens
This network shows the impact of papers produced by James B. Lorens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James B. Lorens. The network helps show where James B. Lorens may publish in the future.
Co-authors
The 25 scholars most cited alongside James B. Lorens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer Hit paper breakdown → | 2010 | 510 |
| 2 | 2009 | 458 | |
| 3 | 2010 | 278 | |
| 4 | 1999 | 271 | |
| 5 | 2009 | 270 | |
| 6 | 1997 | 215 | |
| 7 | 1998 | 188 | |
| 8 | 2005 | 161 | |
| 9 | 2005 | 159 | |
| 10 | 2017 | 119 | |
| 11 | 2009 | 119 | |
| 12 | 1999 | 113 | |
| 13 | 2002 | 110 | |
| 14 | 2015 | 109 | |
| 15 | 2015 | 108 | |
| 16 | 1999 | 106 | |
| 17 | 2007 | 98 | |
| 18 | 1995 | 80 | |
| 19 | 2021 | 75 | |
| 20 | 2001 | 74 |
About James B. Lorens
James B. Lorens is a scholar working on Molecular Biology, Oncology, Immunology, Genetics and Surgery, having authored 141 papers that have together received 5.7k indexed citations. Recurring topics across this work include Phagocytosis and Immune Regulation (48 papers), Pancreatic and Hepatic Oncology Research (30 papers), Cancer Cells and Metastasis (15 papers), Cancer Immunotherapy and Biomarkers (14 papers), Angiogenesis and VEGF in Cancer (14 papers), CRISPR and Genetic Engineering (10 papers), Virus-based gene therapy research (9 papers) and RNA Interference and Gene Delivery (9 papers). The work is most often cited by research in Immunology (1.6k citations), Oncology (1.6k citations), Molecular Biology (3.1k citations), Cancer Research (655 citations) and Biophysics (188 citations). James B. Lorens has collaborated with scholars based in Norway, United States and France. Frequent co-authors include David Micklem, Garry P. Nolan, Wolfgang Link, Crina Tiron, Fabian Zanella, Hallvard Haugen, Christine Gjerdrum, Susan Swift, Donald G. Payan and Bjørn Tore Gjertsen. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, PLoS ONE, Frontiers in Immunology and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.